日韩成人一区二区三区在线观看,亚洲爆乳成av人在线视菜奈实,一级特黄aaa大片在线观看成人一级片在线观看,欧美一级a视频在线观看,久久综合狠狠色综合伊人,国产亂倫近親相姦视频,日韩免费无码视频一区二区三区,97久久精品亚洲中文字幕无码,久爱无码精品免费视频,超碰97人人模人人爽人人

Vaccine
Home > Application > Vaccine > Virus-like particle (VLP) vaccine

Virus-like particle (VLP) vaccine


Most currently available vaccines are mainly based on inactivated or attenuated live vaccines. Although these traditional vaccines have been used effectively against various infectious diseases, some of them have several limitations, including low likelihood of inducing a stronger immune response and their poor efficacy. Recent outbreaks of infectious diseases demonstrate the need to develop robust vaccines to overcome these limitations. The main challenge is to develop new technical approaches and boost immunity without compromising safety, efficacy and tolerability. Recent advances in vaccines based on DNA, mRNA, and recombinant viral vectors provide effective vaccine development methods for difficult-to-target pathogens and control infectious disease outbreaks.

 

Virus-like particle (VLP) technology provides an alternative platform for the development of effective vaccines against serious infectious diseases, and it is being developed in parallel with vaccines based on mRNA and viral vectors. VLPs are also much more immunogenic than other subunit vaccines because they present repetitive epitopes on their surface, making them more reliably detectable by the immune system. On the other hand, subunit vaccines may be less immunogenic due to misfolding of the target antigen or insufficient presentation to the immune system, and moreover, they require adjuvants and repeated vaccinations to elicit an adequate immune response. The term virus-like particle was first described by Fraenkel-Conrat and Williams (1955) by recombining tobacco mosaic virus (TMV) particles from purified RNA and protein components. The potential of these nanostructures to induce potent immune responses was then further investigated. The VLP platform can overcome various problems typically associated with traditional vaccines; specifically, infectivity, reversion to virulent forms, mutation risk associated with live attenuated vaccines, and reduced immunogenicity, toxicity instability, low yield and long formulation time associated with inactivated vaccines.

 

These bio-inspired nanostructures feature repetitive and high-density antigens from different viruses, helping to trigger a strong immune response. Furthermore, these highly immunogenic molecules possess the self-assembling properties of viral proteins. They are biocompatible and have the potential for structural flexibility during synthesis. They can be chemically or genetically modified and exhibit increased stability, uniformity, and functionality, and are considered effective tools in various biomedical applications. Depending on the presence or absence of a lipid membrane, VLPs can be classified as either enveloped or nonenveloped.

 

However, some of the key challenges associated with VLPs are low stability, difficult downstream processes, high production costs, and sensitivity to environmental conditions. Many different VLPs have been synthesized in various expression systems, such as bacteria, yeast, mammalian cells, insect cells, and plants. VLP-based vaccines have the potential to be used to treat various infectious diseases, including HIV, influenza, hepatitis B, hepatitis E, malaria, Ebola virus, SARS-CoV-2, Zika virus, dengue fever, and foot-and-mouth disease, among others. Several VLP-based vaccines have been licensed and marketed, including Engerix-B? and Recombivax HB? for HBV, Gardasil? and Cervarix? for HPV, Hecolin? for HEV, and Mosquirix? for malaria.


Related Products
Contact Us
  • Tel.: +86 021 6434 0155
  • E-Mail: marketing@duoningbio.com
  • Address: Building 30, No. 1525 Minqiang Road, Songjiang District, Shanghai
Message

Copyright ? Shanghai Duoning Biotechnology Co., Ltd. All Rights Reserved Sitemap | Technical Support: Reanod

WeChat
WeChat

Message-

Duoning Biotechnology

+86 021 6434 0155

国产成人久久久精品二区三区| 亚洲AV永久无码精品黑人| 久久国产AVJUST麻豆av天堂电影网| 国内精品露脸在线视频播放 | 午夜福利一级毛片在线视频| 在线播放a欧美专区一区| 国产精品亚洲二区在线观看| 97超级碰碰碰人妻中文| 中文字幕人妻av一区二区| 永久免费无码日韩视频| 亚洲黄片一级在线广播| 波多野结衣多次高潮三个老人| 草草视频在线播放| 97精品国产97久久久久久免费| 欧美一本大道东京热精品| 最新中文字幕第一页| 国产成人无码视频一区二区三区| 亚洲尹人香蕉网在线视颅| 国产内射爽爽大片视频社区在线| 无码一区二区三区免费| 超碰aⅴ人人做人人爽欧美| 国产仑乱老女人露脸的怀孕的| 久久久国产99久久国产一| 成人 污污污在线观看| 亚洲国产成人精品女人久久久国产美女| 桃花视频国产欧美一区二区三区| 丰满少妇人妻hd高清大乳在线| 国产免费AV片无码永久免费| 最近最新MV在线观看免费高清| 国产精品99久久免费观看| 日韩人妻无码专区一本二本| 久久久91人妻无码精品蜜桃HD| 一级做a爰片久久毛片A片秋霞天| 成人AV一区二区电影在线观看| 国产无遮挡无码视频免费软件| 99精品视频免费热播在线观看| 午夜成人无码福利免费视频| 国产精品亚洲专区无码WEB| 免费三级网站国产性自爱拍偷| 亚洲欧美日韩综合蜜桃| 美丽人妻无套中出中文字幕 |